The era of bioengineering: how will this affect the next generation of cancer immunotherapy?
Abstract Background Immunotherapy consists of activating the patient’s immune system to fight cancer and has the great potential of preventing future relapses thanks to immunological memory. A great variety of strategies have emerged to harness the immune system against tumors, from the administrati...
Main Authors: | Michele Graciotti, Cristiana Berti, Harm-Anton Klok, Lana Kandalaft |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://link.springer.com/article/10.1186/s12967-017-1244-2 |
Similar Items
-
IL-15 and a Two-Step Maturation Process Improve Bone Marrow-Derived Dendritic Cell Cancer Vaccine
by: Ananda Mookerjee, et al.
Published: (2019-01-01) -
A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model
by: Ananda Mookerjee, et al.
Published: (2018-05-01) -
Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model
by: Ananda Mookerjee, et al.
Published: (2019-01-01) -
A blueprint of the topology and mechanics of the human ovary for next-generation bioengineering and diagnosis
by: Emna Ouni, et al.
Published: (2021-09-01) -
Melanoma Immunotherapy: Next-Generation Biomarkers
by: Sabrina A. Hogan, et al.
Published: (2018-05-01)